During the past decade, Arthritis and Rheumatology of Georgia conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 12 clinical trials were completed, i.e. on average, 240% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 6 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arthritis and Rheumatology of Georgia" #1 sponsor was "Pfizer" with 4 trials, followed by "Amgen" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Eli Lilly and Company" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arthritis and Rheumatology of Georgia" #1 collaborator was "Incyte Corporation" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Arthritis and Rheumatology of Georgia" are "Rheumatoid Arthritis" (4 trials), "Osteoarthritis" (3 trials), "Arthritis" (2 trials), "Arthritis, Rheumatoid" (2 trials) and "Psoriatic Arthritis" (2 trials). Many other conditions were trialed in "Arthritis and Rheumatology of Georgia" in a lesser frequency.

Most popular intervention types in "Arthritis and Rheumatology of Georgia" are "Drug" (14 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Apremilast 20mg" (2 trials), "Apremilast 30mg" (2 trials), "Tocilizumab" (2 trials) and "tanezumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Arthritis and Rheumatology of Georgia" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Arthritis and Rheumatology of Georgia". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Arthritis and Rheumatology of Georgia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Arthritis and Rheumatology of Georgia, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".